ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
10.57
+0.32 (3.12%)
At close: Jun 26, 2026, 4:00 PM EDT
10.53
-0.04 (-0.38%)
After-hours: Jun 26, 2026, 4:10 PM EDT
ProMIS Neurosciences Employees
As of December 31, 2025, ProMIS Neurosciences had 11 total employees, including 10 full-time and 1 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$3,692,329
Market Cap
94.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| Biomea Fusion | 40 |
| Black Diamond Therapeutics | 21 |
PMN News
- 23 days ago - ProMIS Neurosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - ProMIS Neurosciences to Participate in Upcoming Conferences in June - GlobeNewsWire
- 5 weeks ago - ProMIS Neurosciences Transcript: AGM 2026 - Transcripts
- 5 weeks ago - ProMIS Neurosciences initiated with a Buy at Brookline - TheFly
- 6 weeks ago - ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year - TheFly
- 6 weeks ago - ProMIS Neurosciences Earnings release: Q1 2026 - Filings
- 6 weeks ago - ProMIS Neurosciences Quarterly report: Q1 2026 - Filings
- 6 weeks ago - ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights - GlobeNewsWire